France· FR:63273126
CICLOPIROX OLAMINE ARROW 1%, crème
A medicinal product containing ciclopirox olamine, registered in France by ARROW GENERIQUES, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CICLOPIROX OLAMINE
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302429401 tube(s) aluminium verni époxy-phénols de 30 gEUR 2.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ciclopirox olamine in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCiclopirox olamineBryant Ranch Prepack
- GermanyBatrafenZentiva Pharma Gmbh
- CzechiaBATRAFENZentiva, k.s., Praha
- BelgiumCiclopirox Olamine Polichem 10 mg/mlPolichem
- CanadaLOPROXBAUSCH HEALTH, CANADA INC.
- IrelandStieprox 15 mg/g ShampooGlaxoSmithKline (Ireland) Limited
- FinlandSebiproxGlaxoSmithKline Oy
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Cyprus · Mycomycen
- Czechia · Batrafen, Dafnegin
- Germany · Batrafen, Ciclocutan
- Spain · Capitec, Ciclochem
- Greece · Mycomycen, Neo-Botacreme
- Croatia · Oxolam
- Hungary · Batrafen
- Ireland · Stieprox
- Italy · Bioginal, Dafnegin
- Luxembourg · Mycoster
- Malta · Mycoskin
- Netherlands · Loprox
- Poland · Ciclopirox Ziaja, Dafnegin
- Portugal · Mycoster
- Slovakia · Batrafen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/670578ee-c28a-4a99-b3ed-435ff6d7062d GET /v1/drugs/670578ee-c28a-4a99-b3ed-435ff6d7062d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63273126",
"date_amm": "2021-12-02",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CICLOPIROX OLAMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "crème",
"voies_administration": "cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about ciclopirox olamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.